NIH Not Ready to Buy Trump’s Hype on COVID-19 Convalescent Plasma, Citing ‘Insufficient’ Data

The FDA authorized treating the coronavirus with blood from recovered patients last week, but the NIH says not so fast.

Blake Montgomery 

Former Reporter/Editor

Published Sep. 1 2020 7:55PM EDT 

Blake Montgomery

Former Reporter/Editor

blakersdozen

Got a tip? Send it to The Daily Beast here.